Cyanidin compositions and therapeutic and diagnostic uses theref

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548427, 548455, 530370, 5303871, 53038822, 5303889, 5303887, C07D20902, C07D20956, C01N 3353

Patent

active

061468371

ABSTRACT:
Compositions comprising cyanidin reagents for binding to Fc.gamma.RI receptors, and methods and kits for use therefor are provided.

REFERENCES:
patent: 4857474 (1989-08-01), Waterbury et al.
patent: 4981977 (1991-01-01), Southwick et al.
patent: 5137809 (1992-08-01), Loken et al.
patent: 5234816 (1993-08-01), Terstappen
patent: 5256542 (1993-10-01), Chang
patent: 5268486 (1993-12-01), Waggoner et al.
Ansari, M.O. et al., "Flourochrome Specific PE/CY5 Tandem (Tricolor) Staining is Sensitive and Specific for Acute promyelocytic Leukemia (AML-FAB M3)", Clinical Cytometry Society:Abstracts p. 83 (1994).
Capsoni, Franco et al., "IL-10 up-regulates human monocyte phagocytosis in the presence of IL-4 and IFN-.gamma.", Journal of Leukocyte Biology, vol. 58 pp. 351-358 (1995).
Ceuppens, J. et al, "Defect in the Membrane Expression of High Affinity 72-kD Fc .gamma. Receptors on Phagocytic Cells in Four Healthy Subjects", Journal of Clinical Investigation, vol. 82 pp. 571-578 (1988).
Davis, B.H. et al."Neutrophil CD64 expression: Potential diagnostic indicator of acute inflammation and therapeutic monitor of interferon-.gamma. therapy", Laboratory Hematology, 1 pp. 3-12 (1995).
Dutton, G. "New Moves Attempt to Boost Research on Nutraceuticals", Genetic Engineering News, vol. 16 No. 11 pp. 1,23,27 (1996).
Ericson, S.G. et al."Monoclonal antibody 197 (anti-Fc.gamma.RI) infusion in a patient with immune thrombocytopenia purpura (ITP) results in down-modulation of Fc.gamma.RI on circulating monocytes", British Journal of Haematology, vol. 92 pp. 718-724 (1996).
Ernst, L. et al."Cyanine Dye Labeling Reagents for Sulfhydryl Groups", Cytometry, vol. 10 pp. 3-10 (1989).
Guyre, P. et al."Recombinant Immune Interferon Increases Immunoglobulin G Fc Receptors on Cultured Human Mononuclear Phagocytes", Journal of Clinical Investigation, vol. 72 pp. 393-397 (1983).
Guyre, P."Monocytes and Polymorphonuclear Neutrophils of Patients with Streptococcal pharyngitis Express Increased Numbers of Type 1 IgG Fc Receptors", Journal of Clinical Investigation, vol. 86 pp. 1892-1896 (1990).
Howard, M.R. et al."Variable detection of myeloid antigens in childhood acute lymphoblastic leukaemia", Journal of Clinical Pathology, vol. 47 pp. 1006-1009 (1994).
Immunotech-Coulter Catalog, Cytometry Monoclonal Reagent Guide, pp. 3 (1995).
Krause, D. et al."CD34: Structure, Biology, and Clinical Utility", Blood, vol. 87 No. 1 pp. 1-13 (1996).
Kronick, M."The use of phycobiliproteins as fluorescent labels in immunoassay", Journal of Immunological Methods, vol. 92 pp. 1-13 (1986).
Lohmeyer, J. et al."Multiparameter flow cytometric analysis of inflammatory cells contained in bronchoalveolar lavage fluid", Journal of Immunological Methods, vol. 172 pp. 59-70 (1994).
Majima, T. et al."Unusual Expression of IgG Fc Receptors on Peripheral Granulocytes from Patients with Leukocyte Adhesion Deficiency (CD11/CD18 Deficiency)", Journal of Immunology, vol. 145 No. 6 pp. 1694-1699 (1990).
Morton, H. C. et al."Functional Association between the Human Myeloid Immunoglobin A Fc Receptor (CD89) and Fc .gamma. Chain", Journal of Biological Chemistry, vol. 270 pp. 29781-29787 (1995).
Mujumdar, R. et al."Cyanine Dye Labeling Reagents:Sulfoindocyanine Succinimidyl Esters", Bioconjugate Chemistry, vol. 4 No. 2 pp. 105-111 (1993).
Mujumdar, S. et al."Cyanine-Labeling Reagents: Sulfobenzindocyanine Succinimidyl Esters", Bioconjugate Chemistry, vol. 7 No. 3 pp. 356-362 (1996).
Ravetch, J. et al."Fc Receptors", Annual Review Immunology, vol. 9 pp. 457-492 (1991).
Repp, R. et al."Neutrophils Express the High Affinity Receptor for IgG (Fc.gamma.RI, CD64) After In Vivo Application of Recombinant Human Granulocyte Colony-Stimulating Factor", Blood, vol. 78 No. 4 pp. 885-889 (1991).
Southwick, P. et al."Cyanine Dye Labeling Reagents--Carboxymethylindocyanine Succinimidyl Esters", Cytometry, vol. 11 pp. 418-430 (1990).
Valerius, T. et al."Involvement of the High-Affinity Receptor for IgG (Fc.gamma.RI; CD64) in Enhanced Tumor Cell Cytotoxicity of Neutrophils during Granulocyte Colony-Stimulating Factor Therapy", Blood, vol. 82 No. 3 pp. 931-939 (1993).
Van de Winkel, J.G.J. et al."Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications", Immunology Today, vol. 14 No. 5 pp. 215-221 (1993).
Van den Herik-Oudijk, I. et al."Identification of Signaling Motifs within Human Fc.gamma.RIIa and Fc.gamma.RIIb Isoforms", Blood, vol. 85 No. 8 pp. 2202-2211 (1995).
Van Vugt, M.J. et al."FcR .gamma.-Chain is Essential for both Surface Expression and Function of Human Fc.gamma.RI (CD674) In Vivo", Blood, vol. 87 No. 9 pp. 3593-3599 (1996).
Repp, R. et al."Neutrophils Express the High Affinity Receptor for IgG (Fc.gamma.RI, CD64) After In Vivo Application of Recombinant Human Granulocyte Colony-Stimulating Factor", Blood, vol. 78 No. 4 pp. 885-889 (1991).
Van Vugt, M. et al., "Binding of PE-Cy5 Conjugates to the Human High-Affinity Receptor for IgG (CD64)", Blood, vol. 88 (6), pp. 2358-2360 (1996).
Stewart et al. Clinical Flow Cytometry. Annals of New York Academy of Sciences 677, 94, 1993.
Michon et al. Blood 86: 1124, Aug., 1995.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyanidin compositions and therapeutic and diagnostic uses theref does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyanidin compositions and therapeutic and diagnostic uses theref, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyanidin compositions and therapeutic and diagnostic uses theref will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2063741

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.